MedPath

Comparison of the effect of aromatherapy with lavender and clove essential oil on labor pain and anxiety

Phase 3
Conditions
pain and anxiety of the first stage of labor.
Registration Number
IRCT20230301057585N1
Lead Sponsor
Gonabad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
159
Inclusion Criteria

Women with first and second pregnancy, aged 18-35 years, pregnant with single fetus , having a normal delivery, 38-42 weeks of pregnancy, cephalic presentation, cervical dilatation more than 3 cm.
No history of asthma, sensitivity and allergy according to mother's statements.
Absence of disease and complications of pregnancy and obstetrics (such as: pre-eclampsia - chorioamnionitis - known liver, gallbladder and respiratory disease, decollement and abnormal heartbeat of the fetus at the beginning of the study),
Not having smell problems and allergies to herbal medicines according to the person.
Not having a known anxiety and depression disease according to the person's statements in the medical history and the mother's file.
Not having migraines according to the mother's statements in the medical history.
Not receiving medical painkillers 3 hours before the start of the study.
There is no history of infertility and thyroid disease according to the person's statements in the medical history and the mother's file.
Informed consent of women to participate in the study

Exclusion Criteria

Mother's non-cooperation in completing the checklist and expressing her pain
Departure from the natural course of labor
Having an emergency caesarean section
Allergic to essential oil
Fetal weight less than 2.5 kg or more than 4 kg

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
abor Pain score. Timepoint: At the beginning of the study, dilation 4-5 cm , dilatation 8-10 cm. Method of measurement: Visual Analogue Scale (VAS).;Anxiety score. Timepoint: At the beginning of the study, dilation 4-5 cm , dilatation 8-10 cm. Method of measurement: Spielberger anxiety questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath